Shares of Dr. Lal PathLabs Ltd. were trading around 4% higher on Wednesday, November 4, after the diagnostic services provider announced its September quarter (Q2 FY27) results, reporting double-digit growth in revenue, net profit and operating earnings.
The company reported revenue of ₹873.9 crore for the September quarter, marking a 19.6% increase from ₹730.6 crore in the corresponding quarter last year.
Net profit rose 27.6% year-on-year to ₹192.2 crore, compared with ₹150.6 crore in Q2 FY26. EBITDA increased 24.9% to ₹280 crore from ₹224.1 crore a year ago.
The EBITDA margin also improved to 32.1% in the quarter, compared with 30.7% in the year-ago period.
Along with its quarterly results, the company announced an interim dividend of ₹5 per share, equivalent to 50% of the face value of each share.
Following the earnings announcement, Dr. Lal PathLabs shares were trading around 4% higher at ₹2,000. The stock has gained around 32% so far in 2026.
Dr. Lal PathLabs Q2 Results: Net profit rises 28%, revenue grows 20%; ₹5 interim dividend